Atara Biotherapeutics, Inc. (ATRA)

Atara Biotherapeutics Statistics

Total Valuation

ATRA has a market cap or net worth of $41.01 million. The enterprise value is $53.88 million.

Market Cap	41.01M
Enterprise Value	53.88M

Important Dates

The last earnings date was Thursday, May 15, 2025, before market open.

Earnings Date	May 15, 2025
Ex-Dividend Date	n/a

Share Statistics

ATRA has 5.86 million shares outstanding. The number of shares has increased by 90.64% in one year.

Current Share Class	5.86M
Shares Outstanding	5.86M
Shares Change (YoY)	+90.64%
Shares Change (QoQ)	+1.32%
Owned by Insiders (%)	2.29%
Owned by Institutions (%)	39.11%
Float	4.16M

Valuation Ratios

PE Ratio	n/a
Forward PE	4.23
PS Ratio	0.31
Forward PS	0.88
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	0.27
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.57

Current Ratio	0.57
Quick Ratio	0.47
Debt / Equity	n/a
Debt / EBITDA	1.87
Debt / FCF	n/a
Interest Coverage	-1.85

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-4.55%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-58.55%
Revenue Per Employee	$1.31M
Profits Per Employee	-$102,229
Employee Count	153
Asset Turnover	1.76
Inventory Turnover	n/a

Taxes

Income Tax	-36,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -54.10% in the last 52 weeks. The beta is 0.30, so ATRA's price volatility has been lower than the market average.

Beta (5Y)	0.30
52-Week Price Change	-54.10%
50-Day Moving Average	6.71
200-Day Moving Average	8.77
Relative Strength Index (RSI)	50.37
Average Volume (20 Days)	69,267

Short Selling Information

The latest short interest is 522,139, so 8.91% of the outstanding shares have been sold short.

Short Interest	522,139
Short Previous Month	662,188
Short % of Shares Out	8.91%
Short % of Float	12.55%
Short Ratio (days to cover)	10.55

Income Statement

In the last 12 months, ATRA had revenue of $199.73 million and -$15.64 million in losses. Loss per share was -$1.78.

Revenue	199.73M
Gross Profit	12.54M
Operating Income	-8.28M
Pretax Income	-233.09M
Net Income	-15.64M
EBITDA	-2.83M
EBIT	-8.28M
Loss Per Share	-$1.78

Balance Sheet

The company has $13.84 million in cash and $26.71 million in debt, giving a net cash position of -$12.87 million or -$2.20 per share.

Cash & Cash Equivalents	13.84M
Total Debt	26.71M
Net Cash	-12.87M
Net Cash Per Share	-$2.20
Equity (Book Value)	-55.07M
Book Value Per Share	-9.30
Working Capital	-20.71M

Cash Flow

In the last 12 months, operating cash flow was -$67.24 million and capital expenditures -$119,000, giving a free cash flow of -$67.36 million.

Operating Cash Flow	-67.24M
Capital Expenditures	-119,000
Free Cash Flow	-67.36M
FCF Per Share	-$11.50

Margins

Gross margin is 6.28%, with operating and profit margins of -4.15% and -7.83%.

Gross Margin	6.28%
Operating Margin	-4.15%
Pretax Margin	-7.85%
Profit Margin	-7.83%
EBITDA Margin	-1.42%
EBIT Margin	-4.15%
FCF Margin	n/a

Dividends & Yields

ATRA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-90.64%
Shareholder Yield	-90.64%
Earnings Yield	-38.14%
FCF Yield	-164.25%

Analyst Forecast

The average price target for ATRA is $17.75, which is 152.85% higher than the current price. The consensus rating is "Buy".

Price Target	$17.75
Price Target Difference	152.85%
Analyst Consensus	Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	-2.74%
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on June 20, 2024. It was a reverse split with a ratio of 0.04:1.

Last Split Date	Jun 20, 2024
Split Type	Reverse
Split Ratio	0.04:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2